We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
-7.87%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$12B
AUM Growth
-$1.05B
Cap. Flow
+$29.7M
Cap. Flow %
0.25%
Top 10 Hldgs %
34.83%
Holding
1,447
New
32
Increased
612
Reduced
360
Closed
43

Sector Composition

Rank Sector Weight
1 Real Estate 59.18%
2 Technology 9.44%
3 Healthcare 4.32%
4 Consumer Discretionary 4.16%
5 Financials 4.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WB icon
1376
Weibo
WB
$1.95B
-3,546
Closed -$82K
WVE icon
1377
Wave Life Sciences
WVE
$1.13B
$0 ﹤0.01%
99
XPEV icon
1378
XPeng
XPEV
$12.2B
-22,300
Closed -$708K
QTTB icon
1379
Q32 Bio
QTTB
$467M
$0 ﹤0.01%
6
TECX
1380
Tectonic Therapeutic
TECX
$562M
$0 ﹤0.01%
7
CMRX
1381
DELISTED
Chimerix, Inc.
CMRX
$0 ﹤0.01%
253
SYRS
1382
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$0 ﹤0.01%
10
PSTX
1383
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$0 ﹤0.01%
116
TBIO
1384
DELISTED
Telesis Bio, Inc. Common Stock
TBIO
$0 ﹤0.01%
5
TWOU
1385
PUT
DELISTED
2U Inc
TWOU
-33
Closed -$1K
MRNS
1386
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$0 ﹤0.01%
58
GMDA
1387
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
$0 ﹤0.01%
93
VIEW
1388
DELISTED
View, Inc. Class A Common Stock
VIEW
-725
Closed -$70K
CYT
1389
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
$0 ﹤0.01%
103
GRCL
1390
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
$0 ﹤0.01%
146
ICVX
1391
DELISTED
Icosavax, Inc. Common Stock
ICVX
$0 ﹤0.01%
114
AMTI
1392
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
$0 ﹤0.01%
132
PRTK
1393
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$0 ﹤0.01%
86
SURF
1394
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$0 ﹤0.01%
77
HARP
1395
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$0 ﹤0.01%
5
AMRS
1396
DELISTED
Amyris Inc.
AMRS
-100,000
Closed -$185K
SPPI
1397
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$0 ﹤0.01%
321
EVLO
1398
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$0 ﹤0.01%
8
TCRR
1399
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$0 ﹤0.01%
131
JNCE
1400
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$0 ﹤0.01%
75

Similar funds

Daiwa Securities Group's Q3 2022 Portfolio in Review

As of Q3 2022, Daiwa Securities Group held 1,447 positions worth $12B, down 8% from $13.1B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Daiwa Securities Group's Q3 2022 filing shows 32 new, 612 increased, 360 reduced and 43 closed positions. Its largest new stake was NextEra Energy, Inc. 5.279% Corporate Units: 150,000 shares worth $7.43M. The largest sale was Duke Realty Corp., an estimated $243M.

By sector, the portfolio is most concentrated in Real Estate at 59% of assets, down from 61% a quarter earlier, followed by Technology and Healthcare.

  • Daiwa Securities Group's largest Q3 2022 buy was NextEra Energy, Inc. 5.279% Corporate Units: 150,000 shares worth $7.43M.
  • Daiwa Securities Group added most to First Industrial Realty Trust in Q3 2022, an estimated $172M increase.
  • Daiwa Securities Group's biggest Q3 2022 reduction was Duke Realty Corp., cutting an estimated $243M.
  • Daiwa Securities Group fully exited Chefs' Warehouse in Q3 2022, selling an estimated $2.69M.
  • Daiwa Securities Group's ten largest holdings make up 35% of its $12B portfolio in Q3 2022.
  • Daiwa Securities Group opened 32 new positions and closed 43 in Q3 2022.
  • Daiwa Securities Group's portfolio value fell 8% quarter-over-quarter to $12B.

Based on Daiwa Securities Group's 13F filing for Q3 2022, filed 2 Nov 2022.